These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38975302)

  • 1. Effect of l-oxiracetam and oxiracetam on memory and cognitive impairment in mild-to-moderate traumatic brain injury patients: Study protocol for a randomized controlled trial.
    Liu T; Liu M; Nie M; Zhao Z; Liu X; Qian Y; Yu Y; Sha Z; Wu C; Yuan J; Jiang W; Lv C; Mi L; Tian Y; Zhang J; Jiang R
    Aging Med (Milton); 2024 Jun; 7(3):341-349. PubMed ID: 38975302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oxiracetam in patients with vascular cognitive impairment: A multicenter, randomized, double-blinded, placebo-controlled, phase IV clinical trial.
    Lim JS; Lee J; Kang Y; Park HT; Kim DE; Cha JK; Park TH; Heo JH; Lee KB; Park JM; Oh MS; Kim EG; Chang DI; Heo SH; Park MS; Park H; Yi S; Lee YB; Park KY; Lee SJ; Kim JG; Lee J; Cho KH; Rha JH; Kim YI; Lee JH; Choi JC; Oh KM; Kwon JH; Kim C; Park JH; Jung KH; Sung SM; Chung JW; Lee YS; Kim HY; Cho HJ; Park JW; Moon WJ; Bae HJ
    Contemp Clin Trials; 2023 Mar; 126():107108. PubMed ID: 36724841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.
    Youn DH; Han SW; Kim JT; Choi H; Lee A; Kim N; Jung H; Hong EP; Park CH; Lee Y; Cho SM; Jeon JP
    Acta Neurochir (Wien); 2023 Aug; 165(8):2201-2210. PubMed ID: 37380907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
    Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
    Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial.
    Brawman-Mintzer O; Tang XC; Bizien M; Harvey PD; Horner MD; Arciniegas DB; Raskind M; Johnson-Greene L; Martineau RJ; Hamner M; Rodriguez-Suarez M; Jorge RE; McGarity S; Wortzel HS; Wei Y; Sindowski T; Mintzer J; Kindy AZ; Donovan K; Reda D
    J Neurotrauma; 2021 Jul; 38(14):1943-1952. PubMed ID: 33514274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial.
    Patel MB; McKenna JW; Alvarez JM; Sugiura A; Jenkins JM; Guillamondegui OD; Pandharipande PP
    Trials; 2012 Sep; 13():177. PubMed ID: 23013802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive function training in chronic traumatic brain injury patients: study protocol.
    Krawczyk DC; Han K; Martinez D; Rakic J; Kmiecik MJ; Chang Z; Nguyen L; Lundie M; Cole RC; Nagele M; Didehbani N
    Trials; 2019 Jul; 20(1):435. PubMed ID: 31307502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of prospective memory rehabilitation plus metacognitive skills training for adults with traumatic brain injury: study protocol for a randomized controlled trial.
    Fleming J; Ownsworth T; Doig E; Hutton L; Griffin J; Kendall M; Shum DH
    Trials; 2017 Jan; 18(1):3. PubMed ID: 28057075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults with traumatic brain injury: A study protocol for randomized controlled trial.
    Liu T; Yu Y; Mi L; Zhao Z; Liu M; Wang J; Wang X; Sha Z; Nie M; Jiang W; Wu C; Yuan J; Lv C; Zhao B; Lin K; Li Z; Luo Z; Liu X; Qian Y; Jiang R
    Heliyon; 2024 Sep; 10(17):e37296. PubMed ID: 39319135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined cognitive and vocational interventions after mild to moderate traumatic brain injury: study protocol for a randomized controlled trial.
    Howe EI; Langlo KS; Terjesen HCA; Røe C; Schanke AK; Søberg HL; Sveen U; Aas E; Enehaug H; Alves DE; Klethagen P; Sagstad K; Moen CM; Torsteinsbrend K; Linnestad AM; Nordenmark TH; Rismyhr BS; Wangen G; Lu J; Ponsford J; Twamley EW; Ugelstad H; Spjelkavik Ø; Løvstad M; Andelic N
    Trials; 2017 Oct; 18(1):483. PubMed ID: 29041954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acupuncture on episodic memory for amnesia-type mild cognitive impairment: study protocol of a multicenter, randomized, controlled trial.
    Dai Y; Xia R; Wang D; Li S; Yuan X; Li X; Liu J; Wang M; Kuang Y; Chen S
    BMC Complement Med Ther; 2023 Jul; 23(1):268. PubMed ID: 37507779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.
    Dougall D; Poole N; Agrawal N
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009221. PubMed ID: 26624881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol.
    Pilipenko P; Ivanova AA; Kotsiubinskaya YV; Feigin V; Majdan M; Grigoryeva VN; Khrulev AY
    BMJ Open; 2022 Apr; 12(4):e059167. PubMed ID: 35418437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.
    Niu F; Sharma A; Wang Z; Feng L; Muresanu DF; Sahib S; Tian ZR; Lafuente JV; Buzoianu AD; Castellani RJ; Nozari A; Menon PK; Patnaik R; Wiklund L; Sharma HS
    Prog Brain Res; 2021; 265():139-230. PubMed ID: 34560921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.